Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quantum Biopharma (QNTM) Income from Non-Controlling Interests (2019 - 2025)

Quantum Biopharma's Income from Non-Controlling Interests history spans 7 years, with the latest figure at -$50.2 million for Q4 2025.

  • On a quarterly basis, Income from Non-Controlling Interests fell 820.24% to -$50.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$53.9 million, a 1895.98% decrease, with the full-year FY2025 number at -$27.0 million, down 80.73% from a year prior.
  • Income from Non-Controlling Interests hit -$50.2 million in Q4 2025 for Quantum Biopharma, down from -$4.7 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for QNTM hit a ceiling of $25.4 million in Q2 2023 and a floor of -$50.2 million in Q4 2025.
  • Historically, Income from Non-Controlling Interests has averaged -$5.0 million across 5 years, with a median of -$3.4 million in 2024.
  • Biggest five-year swings in Income from Non-Controlling Interests: surged 454.96% in 2024 and later crashed 820.24% in 2025.
  • Tracing QNTM's Income from Non-Controlling Interests over 5 years: stood at -$13.2 million in 2021, then soared by 144.71% to $5.9 million in 2022, then crashed by 689.46% to -$34.8 million in 2023, then soared by 84.33% to -$5.5 million in 2024, then crashed by 820.24% to -$50.2 million in 2025.
  • Business Quant data shows Income from Non-Controlling Interests for QNTM at -$50.2 million in Q4 2025, -$4.7 million in Q3 2025, and $9.8 million in Q2 2025.